Elite Capital Asset Manager Profile - aVenture Research
Elite Capital is a venture capital and private equity firm operating in China and the United States. The firm primarily focuses on investments in medical device and biopharma companies, typically participating in Series A funding rounds. Their cross-border presence positions them to support companies expanding in these key markets within the healthcare sector.
One of Elite Capital's notable portfolio companies is KBP Biosciences, which has raised a total of $76 million. The firm's investment strategy leverages its expertise in both the Chinese and US markets, providing valuable insights and connections to portfolio companies in the medical and biopharmaceutical industries.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.